Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Gennery

Showing results (181-190 of 297) with videos related to

Pageof 30
Sort By:
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
British Journal of Haematology|April 10, 2026
Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan studySu Han Lum, Sinéad Greener, Irum Latif Memon, et al.
British Journal of Haematology|February 19, 2009
Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growthElena Soncini, Mary A Slatter, Laura B K R Jones, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2018
Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotypeIrit Tirosh, Yasuhiro Yamazaki, Francesco Frugoni, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2015
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiencyChaowan Guo, Yuka Nakazawa, Lisa Woodbine, et al.
European Journal of Immunology|August 11, 2015
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)Jie Zheng, Frank L van de Veerdonk, Katherine L Crossland, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2020
HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiencyGiulia Prunotto, Ugonna T Offor, Sujith Samarasinghe, et al.
The Journal of Allergy and Clinical Immunology. Global|April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysisJennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceMary A Slatter, Kanchan Rao, Intan Juliana Abd Hamid, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2020
Long-term outcomes for adults with chronic granulomatous disease in the United KingdomLuiza C Campos, Giulia Di Colo, Vruti Dattani, et al.
Pageof 30

Showing results (181-190 of 297) with videos related to

Sort By:
Pageof 30
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
British Journal of Haematology|April 10, 2026
Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan studySu Han Lum, Sinéad Greener, Irum Latif Memon, et al.
British Journal of Haematology|February 19, 2009
Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growthElena Soncini, Mary A Slatter, Laura B K R Jones, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2018
Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotypeIrit Tirosh, Yasuhiro Yamazaki, Francesco Frugoni, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2015
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiencyChaowan Guo, Yuka Nakazawa, Lisa Woodbine, et al.
European Journal of Immunology|August 11, 2015
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)Jie Zheng, Frank L van de Veerdonk, Katherine L Crossland, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2020
HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiencyGiulia Prunotto, Ugonna T Offor, Sujith Samarasinghe, et al.
The Journal of Allergy and Clinical Immunology. Global|April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysisJennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceMary A Slatter, Kanchan Rao, Intan Juliana Abd Hamid, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2020
Long-term outcomes for adults with chronic granulomatous disease in the United KingdomLuiza C Campos, Giulia Di Colo, Vruti Dattani, et al.
Pageof 30